Cargando…
Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239861/ https://www.ncbi.nlm.nih.gov/pubmed/34042319 http://dx.doi.org/10.1002/art.41806 |
| _version_ | 1783715116268650496 |
|---|---|
| author | Mortezavi, Mahta Menon, Sujatha Lee, Kristen Rivas, Jose |
| author_facet | Mortezavi, Mahta Menon, Sujatha Lee, Kristen Rivas, Jose |
| author_sort | Mortezavi, Mahta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8239861 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82398612021-06-29 Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases Mortezavi, Mahta Menon, Sujatha Lee, Kristen Rivas, Jose Arthritis Rheumatol Letters John Wiley and Sons Inc. 2021-07-29 2021-09 /pmc/articles/PMC8239861/ /pubmed/34042319 http://dx.doi.org/10.1002/art.41806 Text en © 2021 Pfizer Inc. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters Mortezavi, Mahta Menon, Sujatha Lee, Kristen Rivas, Jose Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases |
| title | Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases |
| title_full | Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases |
| title_fullStr | Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases |
| title_full_unstemmed | Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases |
| title_short | Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases |
| title_sort | use of tofacitinib in the context of covid‐19 vaccination: comment on the american college of rheumatology clinical guidance for covid‐19 vaccination in patients with rheumatic and musculoskeletal diseases |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239861/ https://www.ncbi.nlm.nih.gov/pubmed/34042319 http://dx.doi.org/10.1002/art.41806 |
| work_keys_str_mv | AT mortezavimahta useoftofacitinibinthecontextofcovid19vaccinationcommentontheamericancollegeofrheumatologyclinicalguidanceforcovid19vaccinationinpatientswithrheumaticandmusculoskeletaldiseases AT menonsujatha useoftofacitinibinthecontextofcovid19vaccinationcommentontheamericancollegeofrheumatologyclinicalguidanceforcovid19vaccinationinpatientswithrheumaticandmusculoskeletaldiseases AT leekristen useoftofacitinibinthecontextofcovid19vaccinationcommentontheamericancollegeofrheumatologyclinicalguidanceforcovid19vaccinationinpatientswithrheumaticandmusculoskeletaldiseases AT rivasjose useoftofacitinibinthecontextofcovid19vaccinationcommentontheamericancollegeofrheumatologyclinicalguidanceforcovid19vaccinationinpatientswithrheumaticandmusculoskeletaldiseases |